Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome, 2023, Marinkovic et al.

Discussion in 'Long Covid research' started by SNT Gatchaman, Dec 24, 2023.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,515
    Location:
    Aotearoa New Zealand
    Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome
    Marinkovic, Ksenija; White, David R.; Alderson Myers, Austin; Parker, Katie S.; Arienzo, Donatello; Mason, Graeme F.

    After recovering from the acute COVID-19 illness, a substantial proportion of people continue experiencing post-acute sequelae of COVID-19 (PASC), also termed “long COVID”. Their quality of life is adversely impacted by persistent cognitive dysfunction and affective distress, but the underlying neural mechanisms are poorly understood.

    The present study recruited a group of mostly young, previously healthy adults (24.4 ± 5.2 years of age) who experienced PASC for almost 6 months following a mild acute COVID-19 illness. Confirming prior evidence, they reported noticeable memory and attention deficits, brain fog, depression/anxiety, fatigue, and other symptoms potentially suggestive of excitation/inhibition imbalance. Proton magnetic resonance spectroscopy (1H-MRS) was used to examine the neurochemical aspects of cell signaling with an emphasis on GABA levels in the occipital cortex. The PASC participants were compared to a control (CNT) group matched in demographics, intelligence, and an array of other variables.

    Controlling for tissue composition, biological sex, and alcohol intake, the PASC group had lower GABA+/water than CNT, which correlated with depression and poor sleep quality. The mediation analysis revealed that the impact of PASC on depression was partly mediated by lower GABA+/water, indicative of cortical hyperexcitability as an underlying mechanism. In addition, N-acetylaspartate (NAA) tended to be lower in the PASC group, possibly suggesting compromised neuronal integrity.

    Persistent neuroinflammation may contribute to the pathogenesis of PASC-related neurocognitive dysfunction.

    Link | PDF (Brain Sciences)
     
    Michelle, Kiwipom, shak8 and 7 others like this.
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,121
    Location:
    Aotearoa New Zealand
    Sample size of 18, with their symptoms having reportedly relatively mild impacts. 20 controls
     
    Last edited: Dec 24, 2023
    Michelle, RedFox, EndME and 2 others like this.
  3. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,121
    Location:
    Aotearoa New Zealand
    So the quantification of GABA+ is from one relatively small bit of brain.

    Just noting this. Abnormal results might be the result of some technical problem or some medical problem unique to the subjects, but might also be related to a transient impact of PASC. (It would be good to see this spectral scanning done before and during obvious PEM - I think I might have said that before.)

    Screen Shot 2023-12-25 at 9.20.06 am.png
    The PASC sample had lower GABA+ and NAA (although the difference for NAA was not statistically significant)
     
    Michelle, Kiwipom, RedFox and 5 others like this.

Share This Page